Citius Pharmaceuticals is trading 5.25% up at $0.61 after announcing on September 3, 2026, that CEO Leonard Mazur will present at two upcoming investor conferences and hold one-on-one meetings.
- The company plans to discuss LYMPHIR commercialization and its late-stage pipeline, providing a fresh investor-engagement catalyst.
- Broader support comes from stronger equity markets and a healthcare-sector advance; no additional major company-specific announcement was identified.